Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240643 · ClinicalTrials.gov registry record · Phase 2
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 640
- Enrollment target
NCT00240643: Completed Phase 2 study, sponsored by GlaxoSmithKline.
NCT00240643 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 640 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (381% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00240643, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 640 participants
- Enrollment target
Study Summary
This study will allow determination of the pharmacokinetic and pharmacodynamics of SB424323 in a relevant population. The data from this study will be used along with other data to aid in choosing the most appropriate dose for the later phase study.
Interventions
- DRUG SB424323
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00240643 record still lists
NCT00240643 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (381% higher).
The record links to 0 conditions, and to 1 intervention - of which SB424323 is the first listed.
NCT00240643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00240643 about?
NCT00240643 is a clinical study titled "Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke". This study will allow determination of the pharmacokinetic and pharmacodynamics of SB424323 in a relevant population. The data from this study will be used along with other data to aid in choosing the most appropriate dose for the later phase study.
What is the current status of trial NCT00240643?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 640 participants. The study started on 2005-11. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00240643?
The interventions under investigation include: SB424323 (DRUG).
Who is sponsoring clinical trial NCT00240643?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00240643's enrollment target sits among peer trials
640 51st of 2000 higher than 1,950 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia